Showing results (791-800 of 1,043) with videos related to

Sort By:
Pageof 105
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
International Forum of Allergy & Rhinology|March 17, 2021
Responsiveness and convergent validity of the chronic rhinosinusitis patient-reported outcome (CRS-PRO) measure in CRS patients undergoing endoscopic sinus surgeryKatherine A Lin, Caroline P E Price, Julia H Huang, et al.
The Lancet. Oncology|January 15, 2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trialDavid Cella, Robert J Motzer, Cristina Suarez, et al.
Cancer|July 23, 2011
Patient-reported outcome measures suitable to assessment of patient navigationKevin Fiscella, Sean Ransom, Pascal Jean-Pierre, et al.
Health Marketing Quarterly|May 18, 2004
The effects of continuing medical education credits on physician response rates to a mailed questionnaireMary McGrae McDermott, Philip Greenland, Elizabeth A Hahn, et al.
Contemporary Clinical Trials|January 14, 2018
Optimization of a technology-supported physical activity intervention for breast cancer survivors: Fit2Thrive study protocolSiobhan M Phillips, Linda M Collins, Frank J Penedo, et al.
Cancer|March 18, 2014
Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinomaDavid Cella, Mellar P Davis, Sylvie Négrier, et al.
The Journal of the American Academy of Orthopaedic Surgeons|April 27, 2022
Linking Hip Disability and Osteoarthritis Outcome Score-Physical Function Short Form and PROMIS Physical FunctionMarilyn Heng, Brocha Z Stern, Xiaodan Tang, et al.
The Lancet. Oncology|January 20, 2019
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trialDavid Cella, Viktor Grünwald, Bernard Escudier, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 11, 2017
A method to create a standardized generic and condition-specific patient-reported outcome measure for patient care and healthcare improvementKaren E Schifferdecker, Susan E Yount, Karen Kaiser, et al.
Pageof 105